Green Thumb Industries Inc. (GTBIF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Green Thumb Industries Inc. (GTBIF) trades at $8.14 with AI Score 57/100 (Grade B). Green Thumb Industries Inc. Market cap: $1.89B, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for GTBIF: GTBIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GTBIF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
GTBIF: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.
Green Thumb Industries Inc. (GTBIF) Healthcare & Pipeline Overview
Green Thumb Industries Inc. (GTBIF) is a vertically integrated cannabis company that manufactures, distributes, and retails a portfolio of branded cannabis products in the U.S. adult-use and medical markets. With a focus on branded products and retail expansion, GTBIF aims to capitalize on the growing cannabis market.
What Is the Investment Thesis for GTBIF?
Green Thumb Industries presents a notable research candidate within the expanding cannabis market. With a market capitalization of $1.55 billion and a P/E ratio of 13.11, GTBIF demonstrates strong financial performance, supported by a gross margin of 47.5% and a profit margin of 9.8%. Growth catalysts include ongoing cannabis legalization efforts across various states and the expansion of GTBIF's retail footprint. The company's focus on branded products and vertically integrated operations positions it well to capitalize on increasing consumer demand. Potential risks include regulatory uncertainties and competition from other cannabis operators. GTBIF's beta of 0.90 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
GTBIF Key Highlights
- Market Cap: $1.55B indicates substantial investor confidence and company size within the cannabis industry.
- P/E Ratio: 13.11 suggests the company's stock is reasonably valued compared to its earnings.
- Profit Margin: 9.8% demonstrates the company's ability to generate profit from its revenue.
- Gross Margin: 47.5% reflects efficient production and pricing strategies.
- 77 Retail Stores (as of April 11, 2022): Shows the company's established retail presence and direct-to-consumer sales channel.
Who Are GTBIF's Competitors?
GTBIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ARSUF Fagron N.V. | $26.53 | +0.00% | $1.95B | 54 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $0.22 | +0.00% | $1.10B | 44 |
| GENSF Genus plc | $31.07 | +0.00% | $2.06B | 52 |
| GRRMF Gerresheimer AG | $32.10 | +0.00% | $1.11B | 43 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $25.77 | +0.00% | $1.07B | 50 |
| ALVO Alvotech | $4.17 | -1.18% | 2B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GTBIF's Key Strengths?
- Vertically integrated operations.
- Strong brand portfolio.
- Extensive retail network.
- Experienced management team.
What Are GTBIF's Weaknesses?
- High operating expenses.
- Limited geographic presence compared to larger competitors.
- Dependence on regulatory approvals.
- OTC market listing.
What Could Drive GTBIF Stock Higher?
- Potential federal cannabis legalization in the United States could significantly expand the market for Green Thumb Industries.
- Expansion of retail footprint through new store openings and acquisitions.
- Product innovation and the launch of new cannabis products.
- Increasing consumer acceptance of cannabis for medical and recreational use.
What Are the Key Risks for GTBIF?
- Regulatory uncertainty and changes in cannabis laws.
- Increased competition from other cannabis operators.
- Fluctuations in cannabis prices.
- Changes in consumer preferences.
- Limited access to capital due to federal prohibition.
What Are the Growth Opportunities for GTBIF?
- Expansion into New States: As more states legalize cannabis for medical and recreational use, Green Thumb Industries has the opportunity to expand its operations into new markets. Each new state represents a potential market of millions of consumers, driving revenue growth and increasing brand awareness. The timeline for expansion depends on the regulatory environment in each state, but GTBIF's experience in navigating complex regulatory frameworks gives it a competitive advantage.
- Increased Retail Footprint: Green Thumb Industries can continue to grow by expanding its retail footprint through new store openings and acquisitions. Each new store increases the company's direct-to-consumer sales and provides a platform for promoting its branded products. The company can strategically target locations with high foot traffic and favorable demographics to maximize sales and profitability. This expansion is ongoing, with new stores planned for 2026 and beyond.
- Product Innovation: Green Thumb Industries can drive growth by developing and launching new cannabis products that cater to evolving consumer preferences. This includes new strains of cannabis flower, innovative edibles, and advanced vaping technologies. By staying ahead of the curve and offering unique and high-quality products, GTBIF can attract new customers and increase sales among existing customers. The timeline for product innovation is continuous, with new products launched regularly.
- Strategic Acquisitions: Green Thumb Industries can pursue strategic acquisitions to expand its market share, acquire new technologies, and enter new markets. Acquisitions can provide access to valuable assets, such as cultivation facilities, processing facilities, and retail licenses. By carefully selecting acquisition targets, GTBIF can accelerate its growth and strengthen its competitive position. The timing of acquisitions is opportunistic, depending on market conditions and available opportunities.
- Increased Brand Awareness: Green Thumb Industries can invest in marketing and advertising to increase brand awareness and build customer loyalty. This includes digital marketing, social media campaigns, and partnerships with influencers. By effectively communicating its brand values and product benefits, GTBIF can attract new customers and differentiate itself from competitors. The timeline for brand awareness initiatives is ongoing, with continuous investment in marketing and advertising.
What Opportunities Does GTBIF Have?
- Expansion into new states.
- Increased retail footprint.
- Product innovation.
- Strategic acquisitions.
What Threats Does GTBIF Face?
- Regulatory uncertainty.
- Increased competition.
- Fluctuations in cannabis prices.
- Changes in consumer preferences.
What Are GTBIF's Competitive Advantages?
- Vertically integrated operations provide control over the supply chain and product quality.
- Strong brand portfolio with established brand recognition.
- Extensive retail network provides direct access to consumers.
- Licenses to operate in key cannabis markets create barriers to entry.
What Does GTBIF Do?
Green Thumb Industries Inc. (GTBIF) was founded in 2014 and is headquartered in Chicago, Illinois. The company operates as a cannabis consumer packaged goods company, manufacturing and distributing a diverse range of cannabis products for both medical and adult-use markets in the United States. GTBIF's product portfolio includes cannabis flower, pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products, marketed under brands such as Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM. The company distributes its products through third-party retail stores and directly to consumers through its own network of retail stores. As of April 11, 2022, Green Thumb Industries owned and operated 77 retail stores across the United States. GTBIF's vertically integrated business model allows it to control the entire value chain, from cultivation and processing to retail distribution, ensuring product quality and consistency. The company focuses on building strong brand recognition and customer loyalty through its diverse product offerings and retail experiences.
What Products and Services Does GTBIF Offer?
- Cultivates cannabis plants.
- Manufactures cannabis products, including flower, pre-rolls, concentrates, and edibles.
- Distributes cannabis products to third-party retail stores.
- Operates its own retail stores to sell directly to consumers.
- Develops and markets branded cannabis products under names like Beboe, Dogwalkers, and RHYTHM.
- Focuses on both medical and adult-use cannabis markets.
How Does GTBIF Make Money?
- Vertically integrated operations, from cultivation to retail.
- Generates revenue through wholesale distribution to third-party retailers.
- Direct-to-consumer sales through company-owned retail stores.
- Focus on branded cannabis products with premium pricing.
What Industry Does GTBIF Operate In?
Green Thumb Industries operates in the rapidly growing cannabis industry, driven by increasing legalization and acceptance of cannabis for medical and recreational use. The U.S. cannabis market is projected to reach billions of dollars in the coming years, presenting significant growth opportunities for companies like GTBIF. The competitive landscape includes other major cannabis operators such as ARSUF (Ayr Wellness Inc.), CHIZF (Columbia Care Inc.), GENSF (Cresco Labs Inc.), GRRMF (Curaleaf Holdings Inc.), and KSPHF (Trulieve Cannabis Corp.). GTBIF's vertically integrated model and focus on branded products differentiate it within this competitive market.
Who Are GTBIF's Key Customers?
- Medical cannabis patients seeking therapeutic relief.
- Adult-use cannabis consumers seeking recreational experiences.
- Third-party retail stores that sell cannabis products.
- Wholesale distributors of cannabis products.
GTBIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
GTBIF Latest News
-
Prediction: Green Thumb Industries Stock Will Double Within 3 Years
fool.com · Apr 30, 2026
-
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
marijuanastocks.com · Apr 29, 2026
-
Schedule III for Some, Not All: Understanding the DOJ's Cannabis Shift
zacks.com · Apr 29, 2026
-
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
fool.com · Apr 28, 2026
GTBIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GTBIF.
Price Targets
Wall Street price target analysis for GTBIF.
GTBIF MoonshotScore
What does this score mean?
The MoonshotScore rates GTBIF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Prediction: Green Thumb Industries Stock Will Double Within 3 Years
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
Schedule III for Some, Not All: Understanding the DOJ's Cannabis Shift
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
Leadership: Benjamin Kovler
CEO
Benjamin Kovler is the CEO of Green Thumb Industries Inc. He has a background in finance and investment management. Prior to joining Green Thumb Industries, Kovler worked in the private equity industry, where he focused on investments in consumer and retail companies. He brings a wealth of experience in capital markets, corporate strategy, and operational execution to his role at Green Thumb Industries.
Track Record: Under Benjamin Kovler's leadership, Green Thumb Industries has grown from a small startup to a leading cannabis company with operations in multiple states. He has overseen the company's expansion into new markets, the development of its branded product portfolio, and the growth of its retail network. Kovler has also been instrumental in raising capital to fund the company's growth initiatives.
GTBIF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Green Thumb Industries does not meet the minimum financial standards or disclosure requirements for the OTCQX or OTCQB tiers. Companies in this tier may have limited information available to investors and may be subject to greater risks. Trading on the OTC Other tier differs significantly from trading on major exchanges like the NYSE or NASDAQ, which have stricter listing requirements and greater regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited disclosure requirements increase information asymmetry.
- Lower trading volume can lead to price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- OTC market listing may limit access to institutional investors.
- Potential for delisting if the company fails to meet minimum requirements.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's regulatory filings and licenses.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC trading.
- Established operations in multiple states.
- Strong brand portfolio and retail network.
- Experienced management team.
- Positive media coverage and industry recognition.
- Audited financial statements (if available).
Common Questions About GTBIF (Healthcare)
What does Green Thumb Industries Inc. do?
Green Thumb Industries Inc. is a cannabis consumer packaged goods company that manufactures, distributes, and sells a variety of cannabis products for medical and adult use in the United States. The company operates a vertically integrated business model, controlling the entire value chain from cultivation and processing to retail distribution. GTBIF's product portfolio includes cannabis flower, pre-rolls, concentrates, vapes, edibles, and topicals, marketed under brands such as Beboe, Dogwalkers, and RHYTHM. The company sells its products through third-party retail stores and its own network of retail stores.
What do analysts say about GTBIF stock?
Analyst coverage of Green Thumb Industries is generally positive, with many analysts citing the company's strong growth prospects and vertically integrated business model as key strengths. Valuation metrics vary depending on the analyst, but most agree that GTBIF is attractively valued relative to its growth potential. Key considerations include the company's ability to execute its expansion plans, navigate regulatory challenges, and maintain its competitive position in the rapidly evolving cannabis market. Analyst ratings and price targets should be viewed as opinions and not as guarantees of future performance.
What are the main risks for GTBIF?
The main risks for Green Thumb Industries include regulatory uncertainty, increased competition, and fluctuations in cannabis prices. Regulatory uncertainty stems from the fact that cannabis remains illegal at the federal level in the United States, creating challenges for companies operating in the industry. Increased competition is a risk as more companies enter the cannabis market and existing players expand their operations. Fluctuations in cannabis prices can impact GTBIF's revenue and profitability. The company's OTC listing also poses liquidity and informational risks.
What are the key growth opportunities for GTBIF in healthcare?
Green Thumb Industries can expand its presence in the healthcare sector by developing cannabis-based therapies for specific medical conditions. This includes conducting clinical trials to demonstrate the efficacy of its products and partnering with healthcare providers to promote their use. GTBIF can also target specific patient populations, such as those suffering from chronic pain, anxiety, or sleep disorders. By focusing on the healthcare market, GTBIF can differentiate itself from competitors and build a strong reputation for quality and innovation.
How does Green Thumb Industries Inc. manage regulatory risks associated with cannabis?
Green Thumb Industries manages regulatory risks by maintaining a strong compliance program, engaging with regulators, and advocating for responsible cannabis policies. The company closely monitors changes in cannabis laws and regulations at the state and federal levels and adapts its operations accordingly. GTBIF also works with industry associations and advocacy groups to promote responsible cannabis policies and educate policymakers about the benefits of cannabis legalization. By proactively managing regulatory risks, GTBIF can minimize the potential for disruptions to its business and maintain its license to operate.
What are the key factors to evaluate for GTBIF?
Green Thumb Industries Inc. (GTBIF) holds an AI score of 57/100 (moderate). Not financial advice.
How frequently does GTBIF data refresh on this page?
GTBIF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GTBIF's recent stock price performance?
Green Thumb Industries Inc. (GTBIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The cannabis industry is subject to rapid regulatory changes, which could impact the company's future performance.
- Financial data is based on publicly available information and may be subject to limitations.